147 related articles for article (PubMed ID: 14686730)
1. Metabolic patterns in meningiomas.
Herting B; Meixensberger J; Roggendorf W; Reichmann H
J Neurooncol; 2003 Nov; 65(2):119-23. PubMed ID: 14686730
[TBL] [Abstract][Full Text] [Related]
2. Metabolic patterns in malignant gliomas.
Meixensberger J; Herting B; Roggendorf W; Reichmann H
J Neurooncol; 1995; 24(2):153-61. PubMed ID: 7562002
[TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
4. Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.
Feichtinger RG; Weis S; Mayr JA; Zimmermann FA; Bogner B; Sperl W; Kofler B
Neuro Oncol; 2016 Feb; 18(2):184-94. PubMed ID: 26106125
[TBL] [Abstract][Full Text] [Related]
5. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
[TBL] [Abstract][Full Text] [Related]
6. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
Barresi V; Alafaci C; Salpietro F; Tuccari G
Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
[TBL] [Abstract][Full Text] [Related]
7. Effects of exposure to a simulated altitude of 5500 m on energy metabolic pathways in rats.
Ou LC; Leiter JC
Respir Physiol Neurobiol; 2004 Jul; 141(1):59-71. PubMed ID: 15234676
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
Karamitopoulou E; Perentes E; Tolnay M; Probst A
Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
[TBL] [Abstract][Full Text] [Related]
9. Microcytophotometric analysis of human osteoclast metabolism: lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption.
Dodds RA; Gowen M; Bradbeer JN
J Histochem Cytochem; 1994 May; 42(5):599-606. PubMed ID: 8157931
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
[TBL] [Abstract][Full Text] [Related]
11. P53 overexpression and proliferative potential in malignant meningiomas.
Nagashima G; Aoyagi M; Yamamoto M; Yamamoto S; Wakimoto H; Ohno K; Yamamoto K; Hirakawa K
Acta Neurochir (Wien); 1999; 141(1):53-61; discussion 60-1. PubMed ID: 10071687
[TBL] [Abstract][Full Text] [Related]
12. Lectin binding pattern in meningiomas of various histological subtypes.
Taraszewska A; Matyja E
Folia Neuropathol; 2007; 45(1):9-18. PubMed ID: 17357005
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
Nagaishi M; Yokoo H; Osawa T; Nobusawa S; Tanaka Y; Ikota H; Yoshimoto Y; Nakazato Y
Neuropathology; 2013 Oct; 33(5):526-32. PubMed ID: 23406462
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid content and composition of human meningiomas.
Riboni L; Ghidoni R; Sonnino S; Omodeo-Salè F; Gaini SM; Berra B
Neurochem Pathol; 1984; 2(3):171-88. PubMed ID: 6537468
[TBL] [Abstract][Full Text] [Related]
17. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
Jiang J; Lin C; Liu N; Zhang Z; Sun Y; Fang X; Qi J
APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of meningiomas.
Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
[TBL] [Abstract][Full Text] [Related]
19. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
Utsuki S; Oka H; Sato Y; Kawano N; Tsuchiya B; Kobayashi I; Fujii K
Clin Neuropathol; 2005; 24(1):8-12. PubMed ID: 15696778
[TBL] [Abstract][Full Text] [Related]
20. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
